Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

This study has been completed.
Sponsor:
Information provided by:
University of Illinois at Chicago
ClinicalTrials.gov Identifier:
NCT00490464
First received: June 20, 2007
Last updated: June 21, 2007
Last verified: June 2007
  Purpose

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.


Condition Intervention
Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Drug: Nicardipine and Nipride

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by University of Illinois at Chicago:

Enrollment: 163
Study Start Date: June 2004
Study Completion Date: February 2007
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18-70 years old (inclusive)
  • Admission to NSICU with a diagnosis of SAH or ICH

Exclusion Criteria:

  • Patients who are admitted >48 hours after SAH or ICH
  • Readmission or second SAH
  • Readmission or second ICH
  • Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
  • Women who are pregnant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00490464

Locations
United States, Illinois
University of Illinois at Chicago, UIC
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
University of Illinois at Chicago
Investigators
Principal Investigator: Ben Z Roitberg, MD University of Illinois at Chicago, Department of Neurosurgery
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00490464     History of Changes
Other Study ID Numbers: 2004-0233
Study First Received: June 20, 2007
Last Updated: June 21, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by University of Illinois at Chicago:
Patients with SAH or ICH

Additional relevant MeSH terms:
Hemorrhage
Subarachnoid Hemorrhage
Cerebral Hemorrhage
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Nicardipine
Nitroprusside
Antihypertensive Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions
Calcium Channel Blockers
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Vasodilator Agents
Nitric Oxide Donors

ClinicalTrials.gov processed this record on August 21, 2014